Business Description
Sun Pharma Advanced Research Co Ltd
NAICS : 621511
ISIN : INE232I01014
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.57 | |||||
Equity-to-Asset | 0.24 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.81 | |||||
Beneish M-Score | -0.94 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -37.8 | |||||
3-Year EBITDA Growth Rate | -32.5 | |||||
3-Year EPS without NRI Growth Rate | -27.4 | |||||
3-Year FCF Growth Rate | -32.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.91 | |||||
9-Day RSI | 36.4 | |||||
14-Day RSI | 37.72 | |||||
6-1 Month Momentum % | -48.92 | |||||
12-1 Month Momentum % | 1.59 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.02 | |||||
Quick Ratio | 1.02 | |||||
Cash Ratio | 0.59 | |||||
Days Sales Outstanding | 142.19 | |||||
Days Payable | 477.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.4 | |||||
Shareholder Yield % | 0.97 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -70.61 | |||||
Operating Margin % | -588.73 | |||||
Net Margin % | -566.86 | |||||
FCF Margin % | -666.17 | |||||
ROE % | -119.9 | |||||
ROA % | -57.8 | |||||
ROIC % | -120.4 | |||||
ROC (Joel Greenblatt) % | -356.44 | |||||
ROCE % | -85.28 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 98.21 | |||||
PB Ratio | 53.43 | |||||
Price-to-Tangible-Book | 80.93 | |||||
EV-to-EBIT | -17.21 | |||||
EV-to-EBITDA | -17.79 | |||||
EV-to-Revenue | 96.99 | |||||
EV-to-FCF | -14.76 | |||||
Price-to-Median-PS-Value | 2.14 | |||||
Earnings Yield (Greenblatt) % | -5.81 | |||||
FCF Yield % | -6.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sun Pharma Advanced Research Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 684.053 | ||
EPS (TTM) (₹) | -11.95 | ||
Beta | 1.75 | ||
Volatility % | 60.62 | ||
14-Day RSI | 37.72 | ||
14-Day ATR (₹) | 6.579021 | ||
20-Day SMA (₹) | 215.8595 | ||
12-1 Month Momentum % | 1.59 | ||
52-Week Range (₹) | 196.1 - 472.8 | ||
Shares Outstanding (Mil) | 324.52 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sun Pharma Advanced Research Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sun Pharma Advanced Research Co Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Sun Pharma Advanced Research Co Ltd Frequently Asked Questions
What is Sun Pharma Advanced Research Co Ltd(NSE:SPARC)'s stock price today?
When is next earnings date of Sun Pharma Advanced Research Co Ltd(NSE:SPARC)?
Does Sun Pharma Advanced Research Co Ltd(NSE:SPARC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |